An Evidence-Based Guideline for Surveillance of Patients after Curative Treatment for Colon and Rectal Cancer.
Erin KennedyCaroline ZwaalTim AsmisCharles ChoJacqueline GalicaAlexandra GintyAnand GovindarajanPublished in: Current oncology (Toronto, Ont.) (2022)
For patients with stage I-III colon cancer, a medical history and physical examination should be performed every six months for three years; computed tomography (CT) of the chest-abdomen-pelvis (CT CAP) should be performed at one and three years, or one CT CAP could be performed at 18 months; the use of carcinoembryonic antigen (CEA) is optional if CT imaging is being performed; and surveillance colonoscopy should be performed one year after the initial surgery. The frequency of subsequent surveillance colonoscopy should be dictated by previous findings, but generally, colonoscopies should be performed every five years if the findings are normal. There was insufficient evidence to support these recommendations for patients with rectal cancer, Stage IV colon cancer, and patients over the age of 75 years. Patients should be informed of current recommendations and the treating physician should discuss the specific risks and benefits of each recommendation with their patients.
Keyphrases
- computed tomography
- end stage renal disease
- ejection fraction
- rectal cancer
- newly diagnosed
- prognostic factors
- chronic kidney disease
- healthcare
- image quality
- magnetic resonance imaging
- peritoneal dialysis
- minimally invasive
- risk assessment
- magnetic resonance
- high resolution
- radiation therapy
- patient reported outcomes
- coronary artery disease
- climate change
- acute coronary syndrome
- pet ct
- patient reported
- human health